Opioid detox for Pompano Beach — fentanyl-era protocols, buprenorphine done right.

RECO Island's Delray Beach campus sits 18 miles north of Pompano Beach — about 28 minutes up I-95 — offering genuine separation from Cresthaven, Lighthouse Point, and Hillsboro Shores without leaving South Florida. Opioid detox is physician-led and small-census, with 24/7 nursing, COWS-guided buprenorphine induction (including micro-induction protocols for fentanyl-exposed patients), and a defined pathway into residential treatment on the same campus. No third-party handoffs, no waitlists between levels of care.

For clients in Pompano Beach, the drive to RECO Island’s Delray Beach campus runs 18 miles north on I-95 — about 28 minutes off-peak, longer through rush hour. That is meaningful clinical distance from Cresthaven, Lighthouse Point, Sea Ranch Lakes, and Hillsboro Shores: far enough to break the environmental cues that reinforce use, close enough that family remains reachable for structured weekly sessions and weekend visits. RECO Island’s opioid detox program is physician-led, small-census, and staffed specifically for the fentanyl era — 24/7 nursing, current addiction medicine protocols, and a direct in-house transition into residential treatment rather than a third-party handoff at discharge.

Opioid withdrawal in the fentanyl era

Fentanyl and its analogs — carfentanil, acetylfentanyl, and increasingly xylazine-adulterated combinations — have materially changed the clinical picture of opioid withdrawal. Onset from fentanyl is often faster than the 8-24 hour window characteristic of heroin or short-acting prescription opioids, but the syndrome is also less predictable in intensity and duration because fentanyl accumulates in adipose tissue and releases in an irregular pattern over several days. Patients who present with what looks like classical opioid withdrawal — pupillary dilation, rhinorrhea, piloerection, GI distress, myalgia, restlessness — may still carry significant residual full-agonist activity that complicates buprenorphine induction.

Xylazine complicates the picture further. It is not an opioid, is not reversed by naloxone, and adds sedation, bradycardia, and characteristic skin ulceration to the presentation. RECO Island’s assessment protocol accounts for polysubstance patterns rather than treating opioid withdrawal in isolation, and comfort medication regimens are adjusted for the specific exposure history.

The practical implication is that the pre-fentanyl playbook — wait for moderate COWS, start standard buprenorphine, titrate — increasingly precipitates withdrawal in patients whose exposure history included street fentanyl. Protocols have to evolve with the drug supply, and ours have.

COWS-guided buprenorphine induction

The Clinical Opiate Withdrawal Scale (COWS) scores eleven objective and subjective domains — resting pulse rate, sweating, restlessness, pupil size, bone and joint aches, rhinorrhea or lacrimation, GI upset, tremor, yawning, anxiety or irritability, and gooseflesh skin — producing a total from 0 to 48. Standard buprenorphine induction historically begins at COWS 11 or higher, with an initial dose of 2-4 mg sublingually, reassessment at 60-90 minutes, and titration to a clinically effective dose of 8-16 mg over the first 24 hours.

For fentanyl-exposed patients, RECO Island physicians may elect low-dose or micro-induction protocols — starting at 0.5-1 mg of buprenorphine with small overlapping doses across 3-7 days while any residual full agonist clears. Comfort medications supplement the induction: clonidine 0.1-0.2 mg every 4-6 hours for autonomic symptoms, loperamide for GI, ondansetron for nausea, and methocarbamol or hydroxyzine for musculoskeletal symptoms and anxiety.

Nursing performs COWS scoring every 4 hours during acute withdrawal, with immediate physician escalation for scores above 24 or for signs of medical instability. Vital signs, hydration status, and psychiatric assessment run in parallel. Withdrawal is a medical event with real morbidity — not simply a discomfort to be waited out.

Buprenorphine, methadone, or naltrexone — the MAT decision

Post-detox medication for opioid use disorder has three evidence-based options, and the decision is clinical rather than ideological. Buprenorphine (Suboxone, Subutex, Sublocade monthly injection) is a partial mu-agonist with a ceiling effect on respiratory depression and the strongest evidence base for retention in outpatient care. Methadone is a full agonist dispensed through federally regulated opioid treatment programs, with the deepest evidence for high-severity opioid use disorder but daily-dosing logistics that not every client can sustain. Extended-release naltrexone (Vivitrol, monthly IM injection) is an opioid antagonist that requires a 7-10 day opioid-free period before initiation to avoid precipitated withdrawal — a real barrier that RECO Island’s inpatient stay is uniquely positioned to bridge.

The medication decision is made with the client during the detox stay, based on prior response, coexisting psychiatric conditions, employment and childcare logistics, pregnancy status, and access to prescribers in the client’s home community. Motivational interviewing (MI) grounds this shared decision-making — it is a partnership, not a directive. Switching between medications over the course of long-term recovery is common and clinically appropriate.

Naloxone education and the post-detox safety net

The 30-day period immediately following opioid detox carries the highest overdose mortality risk of any interval in the disease course. Tolerance drops rapidly during the 5-7 day stay, while cue-driven return-to-use risk remains real. A dose that was tolerated pre-detox can be fatal post-detox. This is not an abstract statistic — it is the mechanism behind the deaths that follow discharge when the safety net is inadequate.

Every client discharged from RECO Island opioid detox receives naloxone (intranasal Narcan, 4 mg per spray, two-dose kit) with a prescription and training on administration, rescue breathing, and 911 activation. Designated family members and household contacts are trained on the same protocol. Harm reduction counseling — fentanyl test strips, never-use-alone principles, the Florida Good Samaritan law — is part of discharge planning for every client, including those pursuing abstinence-based maintenance on naltrexone.

MAT continuation is the other half of the safety net. Buprenorphine or naltrexone continuity into residential treatment, partial hospitalization, and intensive outpatient care is the intervention with the strongest mortality-reduction evidence in the addiction medicine literature. Clients are not detoxed off opioids and discharged without a MAT plan unless they have affirmatively declined maintenance after informed discussion.

What the first 24 hours look like

Clients typically arrive at the Delray Beach campus in mild to moderate withdrawal — COWS 5-15 range. The admitting nurse takes vitals, performs a urine drug screen and pregnancy test where indicated, and begins COWS scoring. A physician evaluation follows within hours: medical history, psychiatric review including PHQ-9 and GAD-7 as baseline screeners, prior detox and MAT history, and the induction plan.

Buprenorphine induction begins when COWS crosses the moderate threshold — often overnight or on day two for fentanyl-exposed patients. Sleep is prioritized with hydroxyzine or trazodone rather than benzodiazepines, which carry additive respiratory depression risk when combined with opioid agonists. With client consent, family notification and the first case management contact happen the same day.

Insurance and admissions from Pompano Beach

RECO Island works with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans — both in-network and out-of-network depending on the specific product. Admissions runs a full verification of benefits at no cost, typically within a few hours, and walks families through deductible, coinsurance, and per-diem detox coverage before admission. Self-pay is also available for clients who prefer not to route treatment through insurance.

Same-day admission is the norm for active opioid withdrawal. Transportation from Pompano Beach neighborhoods — Cresthaven, Lighthouse Point, Sea Ranch Lakes, Hillsboro Shores — can be coordinated as part of intake. Clients in acute withdrawal should not drive.

Serving residents of: Cresthaven, Lighthouse Point, Sea Ranch Lakes, Hillsboro Shores.